Skip to content

Vedic Medical Astrology in Essential Hypertension

Vedic Medical Astrology in Essential Hypertension: A Double-blind, Placebo-controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03803306
Enrollment
68
Registered
2019-01-14
Start date
2018-07-12
Completion date
2019-01-06
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Hypertension

Brief summary

Previous studies have explored the correlation and impact of astrological events in relation of diseases, health concerns and relationship between birth chart and disease risk. Cardiovascular conditions, sleep and fertility were found significantly associated with moon phase. However, to best of our knowledge no study has documented the impact of astrological intervention in disease management. This is a randomised, multi-center, double blind placebo controlled clinical trial with two parallel arms. This trial aims to evaluate the effectiveness of Vedic medical astrological intervention for patients with mild to moderate hypertension,with respect to decreasing their blood pressure and improving their quality of life.

Interventions

COMBINATION_PRODUCTVedic Medical Astrology

Individualised astrological based interventions were given including vedic counselling, diet, colors, gems, mantras and the worship deities as an adjuvent to ongoing conventional treatments

OTHERPlacebo vedic medical astrology (PMA)

Conventional treatments were followed with counselling and diet suggestions. astrological interventions were not incorporated during the study phase.

Sponsors

Warwick Research Services (UK) Ltd
CollaboratorUNKNOWN
Swamigal Trust for Vedic Science, India
CollaboratorUNKNOWN
NMP Medical Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients age between 35 and 60 years old, male and female; * Patients who meet the diagnostic criteria of essential hypertension ( * Patients taking antihypertensive drugs under the supervision of physicians. * Patients having understanding of our study and willing to comply with astrological protocol. * Informed consent

Exclusion criteria

* Patients who have been diagnosed as secondary hypertension or malignant hypertension * Patients with comorbid conditions * Patients with a chronic disease associated or psychiatric conditions which might not suitable for the study * Patients who had been treated with any other alternative or complementary medicine during the previous three months

Design outcomes

Primary

MeasureTime frameDescription
Average systolic and average diastolic blood pressurechange from baseline to 12-weeksBlood pressure measured by 24-hour ambulatory blood pressure monitoring

Secondary

MeasureTime frameDescription
Changes in patients Quality of lifechange from baseline to 12-weeksHealth-related quality of life measure by S36

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026